Global OTC Cough, Cold & Allergy Medicine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • OTC Cough, Cold & Allergy Medicine market report explains the definition, types, applications, major countries, and major players of the OTC Cough, Cold & Allergy Medicine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • CSPC

    • China Resources Sanjiu Pharmaceutical

    • GlaxoSmithKline

    • Jiangxi Heying Pharmaceutical

    • Livzon Group

    • Nanjing Chengong Pharmaceutical

    • Novartis AG

    • Xinjiang Quanan Pharmaceutical

    • Johnson & Johnson Service

    • Jiangsu Huayang Pharmaceutical

    • AstraZaneca

    • Allergen

    • Sinopharm Group

    • Sanofi-Aventis

    • Shanghai Pharmaceutical

    • Essence Pharmaceutical Group

    • Bristol-Myers Squib

    • Sun Pharmaceutical Industries

    • Diao Group Chengdu Pharmaceutical

    • Pfizer Inc

    • Reckitt Benckiser Group

    • Toray Industries

    • Procter & Gamble

    • Beijing Jiulong Pharmaceutical

    • Merck

    • Beijing Tongrentang

    • Prestige Brands Holdings

    • Harbin Children's Pharmaceutical

    By Type:

    • Tablet

    • Solution

    • Drops

    • Capsule

    • Granules

    • Syrup

    • Pills

    By End-User:

    • Baby

    • Toddler

    • Preschool Children

    • School-age Children

    • Adult

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global OTC Cough, Cold & Allergy Medicine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 OTC Cough, Cold & Allergy Medicine Outlook to 2028- Original Forecasts

    • 2.2 OTC Cough, Cold & Allergy Medicine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term OTC Cough, Cold & Allergy Medicine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global OTC Cough, Cold & Allergy Medicine Market- Recent Developments

    • 6.1 OTC Cough, Cold & Allergy Medicine Market News and Developments

    • 6.2 OTC Cough, Cold & Allergy Medicine Market Deals Landscape

    7 OTC Cough, Cold & Allergy Medicine Raw Materials and Cost Structure Analysis

    • 7.1 OTC Cough, Cold & Allergy Medicine Key Raw Materials

    • 7.2 OTC Cough, Cold & Allergy Medicine Price Trend of Key Raw Materials

    • 7.3 OTC Cough, Cold & Allergy Medicine Key Suppliers of Raw Materials

    • 7.4 OTC Cough, Cold & Allergy Medicine Market Concentration Rate of Raw Materials

    • 7.5 OTC Cough, Cold & Allergy Medicine Cost Structure Analysis

      • 7.5.1 OTC Cough, Cold & Allergy Medicine Raw Materials Analysis

      • 7.5.2 OTC Cough, Cold & Allergy Medicine Labor Cost Analysis

      • 7.5.3 OTC Cough, Cold & Allergy Medicine Manufacturing Expenses Analysis

    8 Global OTC Cough, Cold & Allergy Medicine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global OTC Cough, Cold & Allergy Medicine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global OTC Cough, Cold & Allergy Medicine Export by Region (Top 10 Countries) (2017-2028)

    9 Global OTC Cough, Cold & Allergy Medicine Market Outlook by Types and Applications to 2022

    • 9.1 Global OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Tablet Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Solution Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Drops Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Capsule Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Granules Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Syrup Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Pills Consumption and Growth Rate (2017-2022)

    • 9.2 Global OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Baby Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Toddler Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Preschool Children Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global School-age Children Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Adult Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise OTC Cough, Cold & Allergy Medicine Market Analysis and Outlook till 2022

    • 10.1 Global OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.2.2 Canada OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.2.3 Mexico OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.3.2 UK OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.3.3 Spain OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.3.4 Belgium OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.3.5 France OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.3.6 Italy OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.3.7 Denmark OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.3.8 Finland OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.3.9 Norway OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.3.10 Sweden OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.3.11 Poland OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.3.12 Russia OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.3.13 Turkey OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.4.2 Japan OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.4.3 India OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.4.4 South Korea OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.4.5 Pakistan OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.4.6 Bangladesh OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.4.7 Indonesia OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.4.8 Thailand OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.4.9 Singapore OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.4.10 Malaysia OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.4.11 Philippines OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.4.12 Vietnam OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.5.2 Colombia OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.5.3 Chile OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.5.4 Argentina OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.5.5 Venezuela OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.5.6 Peru OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.5.7 Puerto Rico OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.5.8 Ecuador OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.6.2 Kuwait OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.6.3 Oman OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.6.4 Qatar OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.7.2 South Africa OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.7.3 Egypt OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.7.4 Algeria OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

      • 10.8.2 New Zealand OTC Cough, Cold & Allergy Medicine Consumption (2017-2022)

    11 Global OTC Cough, Cold & Allergy Medicine Competitive Analysis

    • 11.1 CSPC

      • 11.1.1 CSPC Company Details

      • 11.1.2 CSPC OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 CSPC OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.1.4 CSPC OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 China Resources Sanjiu Pharmaceutical

      • 11.2.1 China Resources Sanjiu Pharmaceutical Company Details

      • 11.2.2 China Resources Sanjiu Pharmaceutical OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 China Resources Sanjiu Pharmaceutical OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.2.4 China Resources Sanjiu Pharmaceutical OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 GlaxoSmithKline

      • 11.3.1 GlaxoSmithKline Company Details

      • 11.3.2 GlaxoSmithKline OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 GlaxoSmithKline OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.3.4 GlaxoSmithKline OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Jiangxi Heying Pharmaceutical

      • 11.4.1 Jiangxi Heying Pharmaceutical Company Details

      • 11.4.2 Jiangxi Heying Pharmaceutical OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Jiangxi Heying Pharmaceutical OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.4.4 Jiangxi Heying Pharmaceutical OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Livzon Group

      • 11.5.1 Livzon Group Company Details

      • 11.5.2 Livzon Group OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Livzon Group OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.5.4 Livzon Group OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Nanjing Chengong Pharmaceutical

      • 11.6.1 Nanjing Chengong Pharmaceutical Company Details

      • 11.6.2 Nanjing Chengong Pharmaceutical OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Nanjing Chengong Pharmaceutical OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.6.4 Nanjing Chengong Pharmaceutical OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Novartis AG

      • 11.7.1 Novartis AG Company Details

      • 11.7.2 Novartis AG OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Novartis AG OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.7.4 Novartis AG OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Xinjiang Quanan Pharmaceutical

      • 11.8.1 Xinjiang Quanan Pharmaceutical Company Details

      • 11.8.2 Xinjiang Quanan Pharmaceutical OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Xinjiang Quanan Pharmaceutical OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.8.4 Xinjiang Quanan Pharmaceutical OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Johnson & Johnson Service

      • 11.9.1 Johnson & Johnson Service Company Details

      • 11.9.2 Johnson & Johnson Service OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Johnson & Johnson Service OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.9.4 Johnson & Johnson Service OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Jiangsu Huayang Pharmaceutical

      • 11.10.1 Jiangsu Huayang Pharmaceutical Company Details

      • 11.10.2 Jiangsu Huayang Pharmaceutical OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Jiangsu Huayang Pharmaceutical OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.10.4 Jiangsu Huayang Pharmaceutical OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 AstraZaneca

      • 11.11.1 AstraZaneca Company Details

      • 11.11.2 AstraZaneca OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 AstraZaneca OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.11.4 AstraZaneca OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Allergen

      • 11.12.1 Allergen Company Details

      • 11.12.2 Allergen OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Allergen OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.12.4 Allergen OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Sinopharm Group

      • 11.13.1 Sinopharm Group Company Details

      • 11.13.2 Sinopharm Group OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Sinopharm Group OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.13.4 Sinopharm Group OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Sanofi-Aventis

      • 11.14.1 Sanofi-Aventis Company Details

      • 11.14.2 Sanofi-Aventis OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Sanofi-Aventis OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.14.4 Sanofi-Aventis OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Shanghai Pharmaceutical

      • 11.15.1 Shanghai Pharmaceutical Company Details

      • 11.15.2 Shanghai Pharmaceutical OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Shanghai Pharmaceutical OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.15.4 Shanghai Pharmaceutical OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 Essence Pharmaceutical Group

      • 11.16.1 Essence Pharmaceutical Group Company Details

      • 11.16.2 Essence Pharmaceutical Group OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 Essence Pharmaceutical Group OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.16.4 Essence Pharmaceutical Group OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    • 11.17 Bristol-Myers Squib

      • 11.17.1 Bristol-Myers Squib Company Details

      • 11.17.2 Bristol-Myers Squib OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.17.3 Bristol-Myers Squib OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.17.4 Bristol-Myers Squib OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.17.5 Recent Research and Development Strategies

    • 11.18 Sun Pharmaceutical Industries

      • 11.18.1 Sun Pharmaceutical Industries Company Details

      • 11.18.2 Sun Pharmaceutical Industries OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.18.3 Sun Pharmaceutical Industries OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.18.4 Sun Pharmaceutical Industries OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.18.5 Recent Research and Development Strategies

    • 11.19 Diao Group Chengdu Pharmaceutical

      • 11.19.1 Diao Group Chengdu Pharmaceutical Company Details

      • 11.19.2 Diao Group Chengdu Pharmaceutical OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.19.3 Diao Group Chengdu Pharmaceutical OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.19.4 Diao Group Chengdu Pharmaceutical OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.19.5 Recent Research and Development Strategies

    • 11.20 Pfizer Inc

      • 11.20.1 Pfizer Inc Company Details

      • 11.20.2 Pfizer Inc OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.20.3 Pfizer Inc OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.20.4 Pfizer Inc OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.20.5 Recent Research and Development Strategies

    • 11.21 Reckitt Benckiser Group

      • 11.21.1 Reckitt Benckiser Group Company Details

      • 11.21.2 Reckitt Benckiser Group OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.21.3 Reckitt Benckiser Group OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.21.4 Reckitt Benckiser Group OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.21.5 Recent Research and Development Strategies

    • 11.22 Toray Industries

      • 11.22.1 Toray Industries Company Details

      • 11.22.2 Toray Industries OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.22.3 Toray Industries OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.22.4 Toray Industries OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.22.5 Recent Research and Development Strategies

    • 11.23 Procter & Gamble

      • 11.23.1 Procter & Gamble Company Details

      • 11.23.2 Procter & Gamble OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.23.3 Procter & Gamble OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.23.4 Procter & Gamble OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.23.5 Recent Research and Development Strategies

    • 11.24 Beijing Jiulong Pharmaceutical

      • 11.24.1 Beijing Jiulong Pharmaceutical Company Details

      • 11.24.2 Beijing Jiulong Pharmaceutical OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.24.3 Beijing Jiulong Pharmaceutical OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.24.4 Beijing Jiulong Pharmaceutical OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.24.5 Recent Research and Development Strategies

    • 11.25 Merck

      • 11.25.1 Merck Company Details

      • 11.25.2 Merck OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.25.3 Merck OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.25.4 Merck OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.25.5 Recent Research and Development Strategies

    • 11.26 Beijing Tongrentang

      • 11.26.1 Beijing Tongrentang Company Details

      • 11.26.2 Beijing Tongrentang OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.26.3 Beijing Tongrentang OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.26.4 Beijing Tongrentang OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.26.5 Recent Research and Development Strategies

    • 11.27 Prestige Brands Holdings

      • 11.27.1 Prestige Brands Holdings Company Details

      • 11.27.2 Prestige Brands Holdings OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.27.3 Prestige Brands Holdings OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.27.4 Prestige Brands Holdings OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.27.5 Recent Research and Development Strategies

    • 11.28 Harbin Children's Pharmaceutical

      • 11.28.1 Harbin Children's Pharmaceutical Company Details

      • 11.28.2 Harbin Children's Pharmaceutical OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.28.3 Harbin Children's Pharmaceutical OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

      • 11.28.4 Harbin Children's Pharmaceutical OTC Cough, Cold & Allergy Medicine Product Portfolio

      • 11.28.5 Recent Research and Development Strategies

    12 Global OTC Cough, Cold & Allergy Medicine Market Outlook by Types and Applications to 2028

    • 12.1 Global OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Tablet Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Solution Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Drops Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Capsule Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Granules Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Syrup Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Pills Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Baby Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Toddler Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Preschool Children Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global School-age Children Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Adult Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise OTC Cough, Cold & Allergy Medicine Market Analysis and Outlook to 2028

    • 13.1 Global OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.2.2 Canada OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.3.2 UK OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.3.3 Spain OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.3.5 France OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.3.6 Italy OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.3.8 Finland OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.3.9 Norway OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.3.11 Poland OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.3.12 Russia OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.4.2 Japan OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.4.3 India OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.5.3 Chile OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.5.6 Peru OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.6.3 Oman OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand OTC Cough, Cold & Allergy Medicine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of OTC Cough, Cold & Allergy Medicine

    • Figure of OTC Cough, Cold & Allergy Medicine Picture

    • Table Global OTC Cough, Cold & Allergy Medicine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global OTC Cough, Cold & Allergy Medicine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Tablet Consumption and Growth Rate (2017-2022)

    • Figure Global Solution Consumption and Growth Rate (2017-2022)

    • Figure Global Drops Consumption and Growth Rate (2017-2022)

    • Figure Global Capsule Consumption and Growth Rate (2017-2022)

    • Figure Global Granules Consumption and Growth Rate (2017-2022)

    • Figure Global Syrup Consumption and Growth Rate (2017-2022)

    • Figure Global Pills Consumption and Growth Rate (2017-2022)

    • Figure Global Baby Consumption and Growth Rate (2017-2022)

    • Figure Global Toddler Consumption and Growth Rate (2017-2022)

    • Figure Global Preschool Children Consumption and Growth Rate (2017-2022)

    • Figure Global School-age Children Consumption and Growth Rate (2017-2022)

    • Figure Global Adult Consumption and Growth Rate (2017-2022)

    • Figure Global OTC Cough, Cold & Allergy Medicine Consumption by Country (2017-2022)

    • Table North America OTC Cough, Cold & Allergy Medicine Consumption by Country (2017-2022)

    • Figure United States OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Canada OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Mexico OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Table Europe OTC Cough, Cold & Allergy Medicine Consumption by Country (2017-2022)

    • Figure Germany OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure UK OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Spain OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Belgium OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure France OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Italy OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Denmark OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Finland OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Norway OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Sweden OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Poland OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Russia OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Turkey OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Table APAC OTC Cough, Cold & Allergy Medicine Consumption by Country (2017-2022)

    • Figure China OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Japan OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure India OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure South Korea OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Thailand OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Singapore OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Philippines OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Table South America OTC Cough, Cold & Allergy Medicine Consumption by Country (2017-2022)

    • Figure Brazil OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Colombia OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Chile OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Argentina OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Peru OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Table GCC OTC Cough, Cold & Allergy Medicine Consumption by Country (2017-2022)

    • Figure Bahrain OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Oman OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Qatar OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Table Africa OTC Cough, Cold & Allergy Medicine Consumption by Country (2017-2022)

    • Figure Nigeria OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure South Africa OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Egypt OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Algeria OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Table Oceania OTC Cough, Cold & Allergy Medicine Consumption by Country (2017-2022)

    • Figure Australia OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand OTC Cough, Cold & Allergy Medicine Consumption and Growth Rate (2017-2022)

    • Table CSPC Company Details

    • Table CSPC OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSPC OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table CSPC OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table China Resources Sanjiu Pharmaceutical Company Details

    • Table China Resources Sanjiu Pharmaceutical OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table China Resources Sanjiu Pharmaceutical OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table China Resources Sanjiu Pharmaceutical OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table GlaxoSmithKline OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Jiangxi Heying Pharmaceutical Company Details

    • Table Jiangxi Heying Pharmaceutical OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangxi Heying Pharmaceutical OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Jiangxi Heying Pharmaceutical OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Livzon Group Company Details

    • Table Livzon Group OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Livzon Group OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Livzon Group OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Nanjing Chengong Pharmaceutical Company Details

    • Table Nanjing Chengong Pharmaceutical OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nanjing Chengong Pharmaceutical OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Nanjing Chengong Pharmaceutical OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Novartis AG Company Details

    • Table Novartis AG OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Novartis AG OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Xinjiang Quanan Pharmaceutical Company Details

    • Table Xinjiang Quanan Pharmaceutical OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Xinjiang Quanan Pharmaceutical OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Xinjiang Quanan Pharmaceutical OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Johnson & Johnson Service Company Details

    • Table Johnson & Johnson Service OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Service OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Johnson & Johnson Service OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Jiangsu Huayang Pharmaceutical Company Details

    • Table Jiangsu Huayang Pharmaceutical OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangsu Huayang Pharmaceutical OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Jiangsu Huayang Pharmaceutical OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table AstraZaneca Company Details

    • Table AstraZaneca OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZaneca OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table AstraZaneca OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Allergen Company Details

    • Table Allergen OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergen OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Allergen OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Sinopharm Group Company Details

    • Table Sinopharm Group OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sinopharm Group OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Sinopharm Group OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Sanofi-Aventis Company Details

    • Table Sanofi-Aventis OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi-Aventis OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Sanofi-Aventis OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Shanghai Pharmaceutical Company Details

    • Table Shanghai Pharmaceutical OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai Pharmaceutical OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Shanghai Pharmaceutical OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Essence Pharmaceutical Group Company Details

    • Table Essence Pharmaceutical Group OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Essence Pharmaceutical Group OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Essence Pharmaceutical Group OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Bristol-Myers Squib Company Details

    • Table Bristol-Myers Squib OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squib OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Bristol-Myers Squib OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Sun Pharmaceutical Industries Company Details

    • Table Sun Pharmaceutical Industries OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Industries OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Sun Pharmaceutical Industries OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Diao Group Chengdu Pharmaceutical Company Details

    • Table Diao Group Chengdu Pharmaceutical OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Diao Group Chengdu Pharmaceutical OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Diao Group Chengdu Pharmaceutical OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Pfizer Inc Company Details

    • Table Pfizer Inc OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Pfizer Inc OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Reckitt Benckiser Group Company Details

    • Table Reckitt Benckiser Group OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Reckitt Benckiser Group OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Reckitt Benckiser Group OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Toray Industries Company Details

    • Table Toray Industries OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Toray Industries OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Toray Industries OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Procter & Gamble Company Details

    • Table Procter & Gamble OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Procter & Gamble OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Procter & Gamble OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Beijing Jiulong Pharmaceutical Company Details

    • Table Beijing Jiulong Pharmaceutical OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beijing Jiulong Pharmaceutical OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Beijing Jiulong Pharmaceutical OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Merck Company Details

    • Table Merck OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Merck OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Beijing Tongrentang Company Details

    • Table Beijing Tongrentang OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beijing Tongrentang OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Beijing Tongrentang OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Prestige Brands Holdings Company Details

    • Table Prestige Brands Holdings OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Prestige Brands Holdings OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Prestige Brands Holdings OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Table Harbin Children's Pharmaceutical Company Details

    • Table Harbin Children's Pharmaceutical OTC Cough, Cold & Allergy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Harbin Children's Pharmaceutical OTC Cough, Cold & Allergy Medicine Main Business and Markets Served

    • Table Harbin Children's Pharmaceutical OTC Cough, Cold & Allergy Medicine Product Portfolio

    • Figure Global Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Solution Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drops Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Capsule Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Granules Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Syrup Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pills Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Baby Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Toddler Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Preschool Children Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global School-age Children Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global OTC Cough, Cold & Allergy Medicine Consumption Forecast by Country (2022-2028)

    • Table North America OTC Cough, Cold & Allergy Medicine Consumption Forecast by Country (2022-2028)

    • Figure United States OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe OTC Cough, Cold & Allergy Medicine Consumption Forecast by Country (2022-2028)

    • Figure Germany OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC OTC Cough, Cold & Allergy Medicine Consumption Forecast by Country (2022-2028)

    • Figure China OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America OTC Cough, Cold & Allergy Medicine Consumption Forecast by Country (2022-2028)

    • Figure Brazil OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC OTC Cough, Cold & Allergy Medicine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa OTC Cough, Cold & Allergy Medicine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania OTC Cough, Cold & Allergy Medicine Consumption Forecast by Country (2022-2028)

    • Figure Australia OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand OTC Cough, Cold & Allergy Medicine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.